Literature DB >> 28479199

Radiosynthesis and evaluation of IGF1R PET ligand [11C]GSK1838705A.

Kiran Kumar Solingapuram Sai1, Jaya Prabhakaran2, Anirudh Sattiraju1, J John Mann2, Akiva Mintz1, J S Dileep Kumar3.   

Abstract

Radiosynthesis and evaluation of [11C]GSK1838705A in mice using microPET and determination of specificity in human GBM UG87MR cells are described herein. The radioligand was synthesized by reacting desmethyl-GSK1838705A with [11C]CH3I using GE FX2MeI module in ∼5% yield (EOS), >95% radiochemical purity and a specific activity of 2.5±0.5Ci/μmol. MicroPET imaging in mice indicated that [11C]GSK1838705A penetrated blood brain barrier (BBB) and showed retention of radiotracer in brain. The radioligand exhibited high uptake in U87MG cells with >70% specific binding to IGF1R. Our experiments suggest that [11C]GSK-1838705A can be a potential PET radiotracer for the in vivo quantification of IGF1R expression in GBM and other brain tumors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Growth factor; IGF1R; Micropet; Radiotracer

Mesh:

Substances:

Year:  2017        PMID: 28479199     DOI: 10.1016/j.bmcl.2017.04.085

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Radiosynthesis and evaluation of [11C]CMP, a high affinity GSK3 ligand.

Authors:  Jaya Prabhakaran; Kiran Kumar Solingapuram Sai; Anirudh Sattiraju; Akiva Mintz; J John Mann; J S Dileep Kumar
Journal:  Bioorg Med Chem Lett       Date:  2019-01-25       Impact factor: 2.823

Review 2.  Molecular Imaging of IGF-1R in Cancer.

Authors:  Yingying Sun; Xilin Sun; Baozhong Shen
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

Review 3.  Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.

Authors:  Julie Bolcaen; Shankari Nair; Cathryn H S Driver; Tebatso M G Boshomane; Thomas Ebenhan; Charlot Vandevoorde
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.